AMTA Conference Comittee


Conference 2000
American Methadone Treatment Association
April 9-12, 2000
San Francisco

Committee Chair John Finger


Committee Members

Assistant to the Chair, Michael Garrett
Co-chair, Alice Diorio

Committee

James DePasquale
Becky Duarte
Barbara Finger
Carlos Franco
Greg Keller

Howard Lotsof
Judith Ostergard
Carmen Pearman
Diane Seaman
Joycelyn Woods

NAMA Events and Activities

Exhibition Booth

Booth Manager: Greg Keller, WI NAMA

Visit NAMA at the Consumer Advocacy Booth during the conference. NAMA would like to thank AFIRM for the donation of the booth.

NAMA Preconference Meeting

How Can We Develop and Strengthen Patient Advocacy Groups?

Day: Sunday
Date: April 9, 2000
Time: 1 – 5 PM

Moderator: John Finger, TexNAMA

Presenters:
Joycelyn Woods, NAMA
Diane Fleury-Seaman, MALTA
Fred Christie, AFIRM
James DePasquale, Membership Director/Chapter Coordinator of NAMA

This special preconference meeting has been developed by the National Alliance of Methadone Advocates (NAMA) in collaboration with other advocacy groups to present concepts that programs can use to promote positive patient outcomes and consumer satisfaction that will be a major focus for the new accreditation system. Ways for providers to develop consumer satisfaction including patient recognition ceremonies, 12 step groups, patient advisory boards, patient advocacy groups and patient organizing drives are some of the strategies that can be utilized by providers and patients to work together and the enormous benefits that will come from this. The intended audience for this presentation includes program directors, medical personnel, doctors, nurses, counselors, social workers, administrative staff, patients, advocates and anyone else included in the methadone field. This meeting will greatly enhance the ability of providers and patients to become one community with the common goal of creating the best methadone system possible.

Supported by the Center for Substance Abuse Treatment

Conference Workshops

D4

Planting the Seeds and Watching the Patients Grow

Day: Tuesday
Date: April 11 2000
Time: 1 – 2:30 PM

Presenters:
Alice Diorio
New England Chapter/National Alliance of Methadone Advocates (NENAMA)
Diane Fleury-Seaman, S.D.C.
Methadone as a Legitimate Treatment Alternative (MALTA)
John McCarthy, M.D.
Bi-Valley Medical Clinic (NAMA Advisory Board)

This interactive workshop uses harm reduction principles and sensitivity training to improve outcomes. Presenters will give a patient’s perspective on how to create individualized treatment based on communication and respect. They will discuss ways to enhance a trusting, therapeutic relationship that conveys compassion and understanding.

NAMA Organization Meeting

To be determined.

Visit the AMTA website at www.assnmethworks.org


Visit the Events Page


Last Update: January 27, 2000


Home

Similar Posts

  • The Methadone Awareness Test

    Admin 05/08/2022

    How much do you really know about methadone? Take NAMA’s Methadone Awareness Test and find out! Most Frequently Asked Question: Is methadone maintenance “trading one addiction for another”     Answer Pregnant women should withdraw or at least lower their dose of methadone so that the baby is not born dependent. True or false?   Answer Methadone…

  • NAMA Policy Statement: “Patient” vs “Client”

    Admin 12/13/2022

    Over the years methadone providers and patients have begun using client in place of patient. While this maybe well intended NAMA is concerned that the results could become damaging to methadone treatment, and most especially to patients. The use of client is deprogating to methadone patients, inferring that their addiction to narcotics is their fault…

  • The First Methadone Advocacy Conference

    Admin 04/25/2022

      Time:  September 26, 1998  9:30 AM to 5 PM Place: Roosevelt Hospital Auditorium  1000 Tenth Avenue  between 58-59th Street  New York City Topics:  A conference for methadone patients and by methadone patients. This important conference gives a voice to the voiceless. Topics discussed will be stigma, prejudice, misunderstandings about methadone, new regulations, physician prescribing…

  • The Ombudsman

    Admin 10/06/2021

    Issue Number 3/4, Spring/Summer 1995 Contents Let’s Stop The Insanity by Anthony Scro Presidential Notes by Stan Novick The Editor’s Letter Methaphobia: Us and Them by Ira Sobel Stigma: The Invisible Barrier by Herman Joseph and Joycelyn Woods Methadone Treatment in New York by M. Grenga and H. S. Nelson Methaphobia Crossword Puzzle The Impact…

  • NAMA Policy Statement: Bottle Recall

    Admin 12/30/2021

    The intent of Bottle Recall initially was to be able to allow patients take home medication and to insure that methadone is not diverted to the streets. However, methadone programs have been giving patients take home medication for years without a serious methadone diversion problem. Furthermore numerous studies have demonstrated that methadone is not a…

  • Food and Drug Administration Alert

    Admin 08/11/2022

    T01-15 April 20, 2001 Print Media: 301-827-6242 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA FDA Warns About Orlaam The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With Addiction…